Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc.（RPHM）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · RPHM · 截至 2026年6月9日
活动摘要
买入笔数
12
P-Purchase only
卖出笔数
2
近12个月
买卖比
6.00
Buy/Sell (by trades)
整体情绪
Reneo Pharmaceuticals, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
RPHM 季度内部人买卖趋势
RPHM 内幕交易卖出 · RPHM 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
RPHM 高管卖出股份 · RPHM 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Sep 25, 2024 | Leonard Braden Michael 10 percent owner | Purchase | 68,746 | $103K | Form 4 |
| Sep 24, 2024 | Leonard Braden Michael 10 percent owner | Purchase | 29,600 | $42K | Form 4 |
| Sep 18, 2024 | Leonard Braden Michael 10 percent owner | Purchase | 806 | $1K | Form 4 |
| Sep 17, 2024 | Leonard Braden Michael 10 percent owner | Purchase | 55,300 | $75K | Form 4 |
| Sep 16, 2024 | Leonard Braden Michael 10 percent owner | Purchase | 172,747 | $237K | Form 4 |
| Sep 13, 2024 | Leonard Braden Michael 10 percent owner | Purchase | 150,000 | $197K | Form 4 |
| Sep 12, 2024 | Leonard Braden Michael 10 percent owner | Purchase | 36,176 | $51K | Form 4 |
| Aug 14, 2024 | Leonard Braden Michael 10 percent owner | Purchase | 100,487 | $142K | Form 4 |
| Aug 13, 2024 | Leonard Braden Michael 10 percent owner | Purchase | 171,339 | $239K | Form 4 |
| May 14, 2024 | Leonard Braden Michael 10 percent owner | Purchase | 335,000 | $516K | Form 4 |
| May 14, 2024 | Leonard Braden Michael 10 percent owner | Purchase | 79,281 | $124K | Form 4 |
| Aug 28, 2023 | Hall Ashley Chief Development Officer | Option | 15,625 | $28K | Form 4 |
| Aug 28, 2023 | Hall Ashley Chief Development Officer | Sale | 15,625 | $98K | Form 4 |
| Jul 26, 2023 | GREY MICHAEL G Executive Chairman · Director | Gift | 50,000 | — | Form 4 |
| Jun 23, 2023 | Novo Holdings A/S 10 percent owner | Sale | 100,000 | $710K | Form 4 |
| May 8, 2023 | O'Donnell Niall Director | Purchase | 125,000 | $1.00M⚡ | Form 4 |
| Aug 12, 2022 | Dorenbaum Alejandro Chief Medical Officer | Gift | 22,348 | — | Form 4 |
| Sep 1, 2022 | Cruse Michael COO | Purchase | 7,500 | $25K | Form 4 |
| Aug 31, 2022 | GREY MICHAEL G Executive Chairman · Director | Option | 50,000 | $99K | Form 4 |
| Aug 29, 2022 | Cruse Michael COO | Purchase | 3,212 | $10K | Form 4 |
| Dec 10, 2021 | Jindal Vineet R. CFO | Award | 30,000 | — | Form 4 |
| Dec 10, 2021 | FLESHER GREGORY J. President and CEO · Director | Award | 100,000 | — | Form 4 |
| Dec 10, 2021 | Dorenbaum Alejandro Chief Medical Officer | Award | 30,000 | — | Form 4 |
| Dec 10, 2021 | Cruse Michael Senior VP-Corporate Operations | Award | 25,000 | — | Form 4 |
| Nov 12, 2021 | Hall Ashley Chief Development Officer | Award | 30,000 | — | Form 4 |
Leonard Braden Michael
10 percent owner
日期
Sep 16
股数
172,747
均价
$1.37
总金额
$237K
Leonard Braden Michael
10 percent owner
日期
Sep 13
股数
150,000
均价
$1.31
总金额
$197K
Leonard Braden Michael
10 percent owner
日期
Aug 14
股数
100,487
均价
$1.41
总金额
$142K
Leonard Braden Michael
10 percent owner
日期
Aug 13
股数
171,339
均价
$1.39
总金额
$239K
Leonard Braden Michael
10 percent owner
日期
May 14
股数
335,000
均价
$1.54
总金额
$516K
GREY MICHAEL G
Executive Chairman · Director
日期
Aug 31
股数
50,000
均价
$1.97
总金额
$99K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 RPHM 内幕交易
RPHM 内幕交易
Reneo Pharmaceuticals, Inc.（RPHM）内幕交易数据来源于公司内部人（包括RPHM）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。RPHM内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Reneo Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
RPHM 内幕交易 · 5个问题Reneo Pharmaceuticals, Inc.（RPHM）的内部人包括高管和董事，如RPHM等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026